 Connection
Felipe Valenca Pereira to Humans
This is a "connection" page, showing publications Felipe Valenca Pereira has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.067 |
|
|
|
-
Ribeiro ÁL, Araújo FP, Martins JP, Lourenço AA, Huang J, Pereira FV, Andrade LAF, Paim AAO, da Fonseca FG, Barbosa-Stancioli EF, Martins-Filho OA, Peruhype-Magalhães V, Tsuji M, Coelho-Dos-Reis JG. A chimeric HLA-A2:ß2M:Ig fusion protein for the study of virus-specific CD8+ T-cells. J Immunol Methods. 2021 05; 492:112997.
Score: 0.009
-
Coelho-Dos-Reis JGA, Funakoshi R, Huang J, Pereira FV, Iketani S, Tsuji M. Functional Human CD141+ Dendritic Cells in Human Immune System Mice. J Infect Dis. 2020 01 02; 221(2):201-213.
Score: 0.008
-
Paschoalin T, Martens AA, Omori ÁT, Pereira FV, Juliano L, Travassos LR, Machado-Santelli GM, Cunha RLOR. Antitumor effect of chiral organotelluranes elicited in a murine melanoma model. Bioorg Med Chem. 2019 06 15; 27(12):2537-2545.
Score: 0.008
-
Rincon M, Pereira FV. A New Perspective: Mitochondrial Stat3 as a Regulator for Lymphocyte Function. Int J Mol Sci. 2018 Jun 04; 19(6).
Score: 0.007
-
Bruder-Nascimento T, Ferreira NS, Zanotto CZ, Ramalho F, Pequeno IO, Olivon VC, Neves KB, Alves-Lopes R, Campos E, Silva CA, Fazan R, Carlos D, Mestriner FL, Prado D, Pereira FV, Braga T, Luiz JP, Cau SB, Elias PC, Moreira AC, Câmara NO, Zamboni DS, Alves-Filho JC, Tostes RC. NLRP3 Inflammasome Mediates Aldosterone-Induced Vascular Damage. Circulation. 2016 Dec 06; 134(23):1866-1880.
Score: 0.006
-
Coelho-Dos-Reis JG, Huang J, Tsao T, Pereira FV, Funakoshi R, Nakajima H, Sugiyama H, Tsuji M. Co-administration of a-GalCer analog and TLR4 agonist induces robust CD8(+) T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cells. Clin Immunol. 2016 07; 168:6-15.
Score: 0.006
-
Pereira FV, Arruda DC, Figueiredo CR, Massaoka MH, Matsuo AL, Bueno V, Rodrigues EG. FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system. Clinics (Sao Paulo). 2013 Jul; 68(7):1018-27.
Score: 0.005
-
Arruda DC, Santos LC, Melo FM, Pereira FV, Figueiredo CR, Matsuo AL, Mortara RA, Juliano MA, Rodrigues EG, Dobroff AS, Polonelli L, Travassos LR. ß-Actin-binding complementarity-determining region 2 of variable heavy chain from monoclonal antibody C7 induces apoptosis in several human tumor cells and is protective against metastatic melanoma. J Biol Chem. 2012 Apr 27; 287(18):14912-22.
Score: 0.005
-
Serrano FA, Matsuo AL, Monteforte PT, Bechara A, Smaili SS, Santana DP, Rodrigues T, Pereira FV, Silva LS, Machado J, Santos EL, Pesquero JB, Martins RM, Travassos LR, Caires AC, Rodrigues EG. A cyclopalladated complex interacts with mitochondrial membrane thiol-groups and induces the apoptotic intrinsic pathway in murine and cisplatin-resistant human tumor cells. BMC Cancer. 2011 Jul 14; 11:296.
Score: 0.004
-
Giddings EL, Champagne DP, Wu MH, Laffin JM, Thornton TM, Valenca-Pereira F, Culp-Hill R, Fortner KA, Romero N, East J, Cao P, Arias-Pulido H, Sidhu KS, Silverstrim B, Kam Y, Kelley S, Pereira M, Bates SE, Bunn JY, Fiering SN, Matthews DE, Robey RW, Stich D, D'Alessandro A, Rincon M. Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance. Nat Commun. 2021 05 14; 12(1):2804.
Score: 0.004
-
Barbier-Torres L, Fortner KA, Iruzubieta P, Delgado TC, Giddings E, Chen Y, Champagne D, Fernández-Ramos D, Mestre D, Gomez-Santos B, Varela-Rey M, de Juan VG, Fernández-Tussy P, Zubiete-Franco I, García-Monzón C, González-Rodríguez Á, Oza D, Valença-Pereira F, Fang Q, Crespo J, Aspichueta P, Tremblay F, Christensen BC, Anguita J, Martínez-Chantar ML, Rincón M. Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation. Nat Commun. 2020 07 03; 11(1):3360.
Score: 0.004
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|